Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00607828 · ClinicalTrials.gov registry record · NA
Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT00607828: Completed NA study, sponsored by University of Nebraska.
NCT00607828 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00607828, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This is a phase I trial studying the side effects and best dose of stereotactic radiation therapy (SRT) in treating patients with advanced liver cancer. Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue.
Primary Outcome
Toxicity as assessed by NCI CTCAE v3.0 (Adverse Events). Due to delayed toxicities attributable to radiotherapy, all toxicities observed within 1 month after SRT will be scored. Dose limiting toxicity (DLT) is defined as any of following toxicities, that is possibly, probably or definitely related to Stereotactic Radiation Therapy (SRT) occurring within 1 month from the start of treatment: 1. grade 4 or 5 hepatic 2. grade 4 or 5 gastrointestinal 3. grade 4 or 5 thrombocytopenia 4. grade 4 hepat
Interventions
- RADIATION stereotactic body radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2007-11-16 |
| Est. Completion | 2017-02-15 |
| Phase | NA |
What the finished NCT00607828 record still lists
NCT00607828 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which stereotactic body radiation therapy is the first listed.
NCT00607828 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00607828 about?
NCT00607828 is a clinical study titled "Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer". This is a phase I trial studying the side effects and best dose of stereotactic radiation therapy (SRT) in treating patients with advanced liver cancer. Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue.
What is the current status of trial NCT00607828?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2007-11-16. Estimated completion is 2017-02-15.
What interventions are being tested in trial NCT00607828?
The interventions under investigation include: stereotactic body radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00607828?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00607828's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI